Old Web
English
Sign In
Acemap
>
authorDetail
>
Divyanshu Dua
Divyanshu Dua
St Thomas' Hospital
Pathology
Medicine
Biomarker (medicine)
Clinical trial
Personalized medicine
4
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
First-in-human phase 1 study of the PARP/tankyrase inhibitor 2X-121 (E7449) as monotherapy in patients with advanced solid tumors and validation of a novel drug response predictor (DRP) mRNA biomarker.
2018
Journal of Clinical Oncology
Elizabeth R. Plummer
Divyanshu Dua
Nicola Cresti
Aneta Suder
Yvette Drew
Peter Stephens
Marie Foegh
Steen Knudsen
Sharon McGonigle
Barbara Ink
Debashis Sarker
Show All
Source
Cite
Save
Citations (4)
Patients' Perceptions of Research Biopsies in Phase I Oncology Trials
2015
Oncology
Charlotte Lemech
Divyanshu Dua
Joshua Newmark
Matilde Saggese
Emily Simmons
Paulina Spiliopoulou
Hendrik-Tobias Arkenau
Show All
Source
Cite
Save
Citations (10)
Phase 1 study of the PARP inhibitor E7449 as a single agent in patients with advanced solid tumors or B-cell lymphoma.
2014
Journal of Clinical Oncology
Ruth Plummer
Divyanshu Dua
Nicola Cresti
Aneta Suder
Yvette Drew
Vasanthi Prathapan
Peter Stephens
Jared K Thornton
B.D.L. Heras
Barbara Ink
Lucy Lee
Mark Matijevic
Shannon McGrath
Debashis Sarker
Show All
Source
Cite
Save
Citations (3)
Research biopsies in the context of early phase oncology studies: clinical and ethical considerations
2013
Oncology Reviews
Matilde Saggese
Divyanshu Dua
Emily Simmons
Charlotte Lemech
Hendrik-Tobias Arkenau
Show All
Source
Cite
Save
Citations (12)
1